苏试试验(300416) - 2021 Q3 - 季度财报

Revenue and Profitability - Revenue for Q3 2021 reached ¥382,060,610.28, an increase of 22.48% year-over-year, while total revenue for the year-to-date was ¥1,056,682,992.28, up 29.45% compared to the same period last year[3] - Net profit attributable to shareholders for Q3 2021 was ¥49,946,431.93, representing a 79.02% increase year-over-year, with year-to-date net profit at ¥131,461,575.04, up 70.54%[3] - The basic earnings per share for Q3 2021 was ¥0.1894, a 79.53% increase compared to the same period last year, while year-to-date earnings per share was ¥0.4985, up 70.95%[3] - Total operating revenue for the current period reached ¥1,056,682,992.28, a 29.4% increase from ¥816,283,512.70 in the previous period[26] - Net profit for the current period was ¥151,279,298.81, compared to ¥86,490,114.47 in the previous period, indicating a growth of 74.8%[29] - The company reported a total comprehensive income of ¥151,157,744.68, compared to ¥86,490,114.47 in the previous period, indicating overall financial improvement[38] Assets and Liabilities - Total assets as of the end of Q3 2021 amounted to ¥3,073,635,604.40, reflecting a 19.17% increase from the end of the previous year[3] - The total assets of Suzhou Su Test Group Co., Ltd. reached RMB 3,073,635,604.40, an increase from RMB 2,579,225,253.96 at the end of 2020, representing a growth of approximately 19.2%[18] - The total liabilities increased to RMB 1,242,432,377.45 from RMB 1,033,811,149.14, indicating a growth of approximately 20.1%[21] - Total liabilities increased to ¥1,881,252,902.82 from ¥1,444,136,587.10, indicating a rise in financial obligations[24] - Total equity rose to ¥1,192,382,701.58 from ¥1,135,088,666.86, reflecting a healthy growth in shareholder value[24] - The company’s total equity attributable to shareholders was ¥1,070,239,699.96, a 4.71% increase from the end of the previous year[5] Cash Flow - Cash flow from operating activities for the year-to-date increased by 134.30%, attributed to improved collection of sales receivables[9] - Cash flow from operating activities was ¥1,119,834,343.88, compared to ¥797,619,251.26 in the previous period, showing a strong cash generation capability[41] - Operating cash inflow totaled CNY 1,149,669,865.34, an increase from CNY 827,222,544.72 year-over-year[44] - Net cash flow from operating activities was CNY 75,960,781.00, up from CNY 32,419,966.90 year-over-year[44] - Cash outflow from investing activities was CNY 324,497,193.80, a decrease from CNY 413,867,186.93 in the previous year[47] - Net cash flow from investing activities was -CNY 188,478,770.27, improving from -CNY 412,417,438.11 year-over-year[47] Research and Development - Research and development expenses increased by 40.53% year-over-year due to higher investment in R&D projects[9] - Research and development expenses for the current period were ¥74,200,893.12, up from ¥52,802,262.72, highlighting the company's commitment to innovation[29] Investments - Long-term equity investments grew by 174.79% compared to the beginning of the year, primarily due to increased investment in a subsidiary[6] - The company reported a significant increase in long-term equity investments, rising to RMB 13,464,772.95 from RMB 4,900,000.00, a growth of approximately 174.4%[18] Other Financial Metrics - The company reported a 63.89% increase in income tax expenses, driven by higher taxable income resulting from increased revenue[9] - The company’s cash and cash equivalents decreased to RMB 368,519,324.20 from RMB 424,411,861.79, a decline of about 13.2% year-over-year[18] - Accounts receivable increased significantly to RMB 604,775,846.38 from RMB 462,475,076.69, marking a rise of approximately 30.7%[18] - Inventory levels rose to RMB 354,980,988.32, up from RMB 282,230,789.21, reflecting an increase of around 25.7%[18] - The company has a deferred income tax liability of approximately 9.12 million, reflecting future tax obligations[54] Financing Activities - The company issued 3.1 million convertible bonds with a total value of RMB 31,000,000, which were approved by the China Securities Regulatory Commission[15] - The adjusted conversion price for the convertible bonds was set at RMB 18.28 per share, down from the previous price of RMB 23.86[17] - The company is actively promoting the issuance of shares to specific investors, following approval from the Shenzhen Stock Exchange[15]